Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye Disease

Trial Profile

Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye Disease

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Oct 2018

At a glance

  • Drugs Perfluorohexyloctane (Primary) ; Sodium chloride
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Sponsors Novaliq
  • Most Recent Events

    • 17 Oct 2018 According to a Novaliq media release, data will be presented during the Ophthalmology Innovation Summit (OIS@AAO) in 2018
    • 27 Apr 2018 New trial record
    • 24 Apr 2018 According to a Novaliq media release, posters will be presented at the 2018 Association for Research in Vision and Ophthalmology (ARVO) Meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top